Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mutaflor gut colonization study in healthy adults
ChiCTR2200061970Phase 4Not yet recruiting
- Sponsor
- Southern Medical University Zhujiang Hospital
- Start
- Dec 2021
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of escherichia coli nissle 1917 (2 arms), sponsored by Southern Medical University Zhujiang Hospital. Primary endpoints: Microbiome, Metabolomics and 2 more. Planned start Dec 2021; status: not yet recruiting.
02
Drugs
escherichia coli nissle 1917
Beyond the preview
Go deeper on ChiCTR2200061970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200061970.